UNH

Unitedhealth Group
D

UNH

Arincen63/100B

Unitedhealth Group total debt 1985–2026

Unitedhealth Group's total debt was 74.33B USD on 30 September 2026, down 7.2% on a year before. At the end of fiscal year 2025 it was 78.39B USD.

Last updated 4 Nov 2026 · Next report 20 Jan 2027

Total debt

Growth

Fiscal yearPeriod endingTotal debtGrowthCash and short-term investmentsNet cashDebt to equity
Latest quarter30 Sept 202674.33B-7.24%28.55B-45.78B0.71
FY202531 Dec 202578.39B+1.93%28.12B-50.27B0.83
FY202431 Dec 202476.90B+14.04%29.11B-47.79B0.83
FY202331 Dec 202367.44B+17.03%29.63B-37.81B0.76
FY202231 Dec 202257.62B+25.26%27.91B-29.71B0.74
FY202131 Dec 202146.00B+5.83%23.91B-22.10B0.64
FY202031 Dec 202043.47B+6.86%19.78B-23.69B0.66
FY201931 Dec 201940.68B+11.28%14.25B-26.43B0.71
FY201831 Dec 201836.55B+15.34%14.32B-22.23B0.71
FY201731 Dec 201731.69B-3.88%15.49B-16.20B0.64
FY201631 Dec 201632.97B+2.73%13.28B-19.70B0.86
FY201531 Dec 201532.09B+84.38%12.91B-19.18B0.95
FY201431 Dec 201417.41B+3.24%9.24B-8.17B0.54
FY201331 Dec 201316.86B+0.63%9.21B-7.65B0.52
FY201231 Dec 201216.75B+43.96%11.44B-5.32B0.54
FY201131 Dec 201111.64B+4.45%12.01B368.00M0.41
FY201031 Dec 201011.14B-0.28%11.20B53.00M0.43
FY200931 Dec 200911.17B-12.67%11.04B-134.00M0.47
FY200831 Dec 200812.79B+16.21%8.21B-4.59B0.62
FY200731 Dec 200711.01B+47.65%9.62B-1.39B0.55
FY200631 Dec 20067.46B+4.85%10.94B3.48B0.36
FY200531 Dec 20057.11B+76.76%6.01B-1.10B0.40
FY200431 Dec 20044.02B+103.28%4.51B482.00M0.38
FY200331 Dec 20031.98B+12.38%2.75B769.00M0.39
FY200231 Dec 20021.76B+11.17%1.83B70.00M0.40
FY200131 Dec 20011.58B+31.02%1.81B226.00M0.41
FY200031 Dec 20001.21B+22.00%1.62B410.00M0.33
FY199931 Dec 1999991.00M+39.97%2.15B1.16B0.26
FY199831 Dec 1998708.00M+3,626.32%1.81B1.11B0.18
FY199731 Dec 199719.00M-38.23%1.26B1.24B0.00
FY199631 Dec 199630.76M-21.06%1.65B1.62B0.01
FY199531 Dec 199538.97M+60.54%1.80B1.76B0.01
FY199431 Dec 199424.28M+3,367.86%1.65B1.63B0.01
FY199331 Dec 1993700.00K+75.00%146.40M145.70M0.00
FY199231 Dec 1992400.00K-88.24%128.70M128.30M0.00
FY199131 Dec 19913.40M-51.43%138.00M134.60M0.01
FY199031 Dec 19907.00M-87.99%53.90M46.90M0.06
FY198931 Dec 198958.30M-2.83%63.70M5.40M0.97
FY198831 Dec 198860.00M-4.46%95.10M35.10M3.87
FY198731 Dec 198762.80M+18.71%61.10M-1.70M1.51
FY198631 Dec 198652.90M—48.50M-4.40M0.96
FY198531 Dec 19850.00—17.10M17.10M0.00

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Total debt counts commercial paper, term debt and lease liabilities.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Stock buybacks,Balance sheet

Common questions about Unitedhealth Group's debt

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.